Drug Type Small molecule drug |
Synonyms EMB 001C, EMB-001, EMB-001C + [1] |
Target |
Action inhibitors, positive allosteric modulator |
Mechanism CYP11B1 inhibitors(Steroid 11-beta-hydroxylase inhibitors), GABAA receptor positive allosteric modulator(Gamma-aminobutyric acid A receptor positive allosteric modulator) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2/3 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H11ClN2O2 |
InChIKeyADIMAYPTOBDMTL-UHFFFAOYSA-N |
CAS Registry604-75-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Smoking Cessation | Phase 3 | United States | 19 May 2021 | |
Smoking Cessation | Phase 3 | United States | 19 May 2021 | |
Tobacco Use Disorder | Phase 3 | United States | 19 May 2021 | |
Tobacco Use Disorder | Phase 3 | United States | 19 May 2021 | |
Cocaine-Related Disorders | Phase 2 | United States | 29 Jul 2020 |